TY - JOUR
T1 - The likelihood of reaching minimum clinically important difference and substantial clinical benefit at 2 years following a 3-column osteotomy
T2 - Analysis of 140 patients
AU - International Spine Study Group
AU - Fakurnejad, Shayan
AU - Scheer, Justin K.
AU - Lafage, Virginie
AU - Smith, Justin S.
AU - Deviren, Vedat
AU - Hostin, Richard
AU - Mundis, Gregory M.
AU - Burton, Douglas C.
AU - Klineberg, Eric
AU - Gupta, Munish
AU - Kebaish, Khaled
AU - Shaffrey, Christopher I.
AU - Bess, Shay
AU - Schwab, Frank
AU - Ames, Christopher P.
N1 - Funding Information:
The International Spine Study Group Foundation, through which this study was conducted, is funded through research grants from DePuy Spine and individual donations. Dr. Ames is a consultant for DePuy, Medtronic, and Stryker; owns stock in Doctors Research Group and Baxano Surgical; holds patents with Fish & Richardson, P.C.; and has received royalties from Aesculap and Biomet Spine. Dr. Smith is a consultant for Biomet, NuVasive, and Cerapedics and has received teaching honoraria from Globus, Medtronic, and DePuy. Dr. Deviren is a consultant for Guidepoint, NuVasive, and Stryker. Dr. Lafage is a consultant for Medicrea and teaches and presents for DePuy, K2M, NuVasive, and Nemaris INC. Dr. Schwab is a consultant for MSD, K2M, DePuy, and Medicrea; receives clinical and research support from DePuy, MSD, and AO; holds patents with MSD, Nemaris, K2M, and NuVasive; and teaches and presents for MSD, Nemaris INC, and K2M. Dr. Burton is a consultant for, holds patents with, and receives clinical or research support from DePuy Spine. Dr. Hostin is a consultant for DePuy; receives clinical and research support from DePuy, NuVasive, Seeger, DJO, and K2M. Dr. Gupta is a consultant for DePuy, Medtronic, and Medicrea; owns stock in Johnson and Johnson, Pfizer, Proctor and Gamble, and Pioneer; and serves as a treasurer and board member for DePuy. Dr. Bess is a consultant for K2M, AlloSource, and NuVasive and receives clinical and research support from DePuy, Medtronic, and Innovasis. Dr. Mundis is a consultant for NuVasive, K2M, Misonix, and Medicrea and serves as a board member for K2M and NuVasive. Dr. Klineberg has received speaker's fees and fellowship grants from DePuy Synthes, and AOSpine and has received an OREF grant. Dr. Shaffrey is a consultant for Biomet, Globus, Medtronic, NuVasive, and Stryker; owns stock in NuVasive; and holds patents with and receives royalties from Biomet, Medtronic, and NuVasive.
Publisher Copyright:
©AANS, 2015.
PY - 2015/9
Y1 - 2015/9
N2 - OBJECT: Three-column osteotomies (3COs) are technically challenging techniques for correcting severe rigid spinal deformities. The impact of these interventions on outcomes reaching minimum clinically important difference (MCID) or substantial clinical benefit (SCB) is unclear. The objective of this study was to determine the rates of MCID and SCB in standard health-related quality of life (HRQOL) measures after 3COs in patients with adult spinal deformity (ASD). The impacts of location of the uppermost instrumented vertebra (UIV) on clinical outcomes and of maintenance on sagittal correction at 2 years postoperatively were also examined. METHODS: The authors conducted a retrospective multicenter analysis of the records from adult patients who underwent 3CO with complete 2-year radiographic and clinical follow-ups. Cases were categorized according to established radiographic thresholds for pelvic tilt (> 22°), sagittal vertical axis (> 4.7 cm), and the mismatch between pelvic incidence and lumbar lordosis (> 11°). The cases were also analyzed on the basis of a UIV in the upper thoracic (T1-6) or thoracolumbar (T9-L1) region. Patient-reported outcome measures evaluated preoperatively and 2 years postoperatively included Oswestry Disability Index (ODI) scores, the Physical Component Summary and Mental Component Summary (MCS) scores of the 36-Item Short Form Health Survey, and Scoliosis Research Society-22 questionnaire (SRS-22) scores. The percentages of patients whose outcomes for these measures met MCID and SCB were compared among the groups. RESULTS: Data from 140 patients (101 women and 39 men) were included in the analysis; the average patient age was 57.3 ± 12.4 years (range 20-82 years). Of these patients, 94 had undergone only pedicle subtraction osteotomy (PSO) and 42 only vertebral column resection (VCR); 113 patients had a UIV in the upper thoracic (n = 63) or thoracolumbar region (n = 50). On average, 2 years postoperatively the patients had significantly improved in all HRQOL measures except the MCS score. For the entire patient cohort, the improvements ranged from 57.6% for the SRS-22 pain score MCID to 24.4% for the ODI score SCB. For patients undergoing PSO or VCR, the likelihood of their outcomes reaching MCID or SCB ranged from 24.3% to 62.3% and from 16.2% to 47.8%, respectively. The SRS-22 self-image score of patients who had a UIV in the upper thoracic region reached MCID significantly more than that of patients who had a UIV in the thoracolumbar region (70.6% vs 41.9%, p = 0.0281). All other outcomes were similar for UIVs of upper thoracic and thoracolumbar regions. Comparison of patients whose spines were above or below the radiographic thresholds associated with disability indicated similar rates of meeting MCID and SCB for HRQOL at the 2-year follow-up. CONCLUSIONS: Outcomes for patients having UIVs in the upper thoracic region were no more likely to meet MCID or SCB than for those having UIVs in the thoracolumbar region, except for the MCID in the SRS-22 self-image measure. The HRQOL outcomes in patients who had optimal sagittal correction according to radiographic thresholds determined preoperatively were not significantly more likely to reach MCID or SCB at the 2-year follow-up. Future work needs to determine whether the Schwab preoperative radiographic thresholds for severe disability apply in postoperative settings.
AB - OBJECT: Three-column osteotomies (3COs) are technically challenging techniques for correcting severe rigid spinal deformities. The impact of these interventions on outcomes reaching minimum clinically important difference (MCID) or substantial clinical benefit (SCB) is unclear. The objective of this study was to determine the rates of MCID and SCB in standard health-related quality of life (HRQOL) measures after 3COs in patients with adult spinal deformity (ASD). The impacts of location of the uppermost instrumented vertebra (UIV) on clinical outcomes and of maintenance on sagittal correction at 2 years postoperatively were also examined. METHODS: The authors conducted a retrospective multicenter analysis of the records from adult patients who underwent 3CO with complete 2-year radiographic and clinical follow-ups. Cases were categorized according to established radiographic thresholds for pelvic tilt (> 22°), sagittal vertical axis (> 4.7 cm), and the mismatch between pelvic incidence and lumbar lordosis (> 11°). The cases were also analyzed on the basis of a UIV in the upper thoracic (T1-6) or thoracolumbar (T9-L1) region. Patient-reported outcome measures evaluated preoperatively and 2 years postoperatively included Oswestry Disability Index (ODI) scores, the Physical Component Summary and Mental Component Summary (MCS) scores of the 36-Item Short Form Health Survey, and Scoliosis Research Society-22 questionnaire (SRS-22) scores. The percentages of patients whose outcomes for these measures met MCID and SCB were compared among the groups. RESULTS: Data from 140 patients (101 women and 39 men) were included in the analysis; the average patient age was 57.3 ± 12.4 years (range 20-82 years). Of these patients, 94 had undergone only pedicle subtraction osteotomy (PSO) and 42 only vertebral column resection (VCR); 113 patients had a UIV in the upper thoracic (n = 63) or thoracolumbar region (n = 50). On average, 2 years postoperatively the patients had significantly improved in all HRQOL measures except the MCS score. For the entire patient cohort, the improvements ranged from 57.6% for the SRS-22 pain score MCID to 24.4% for the ODI score SCB. For patients undergoing PSO or VCR, the likelihood of their outcomes reaching MCID or SCB ranged from 24.3% to 62.3% and from 16.2% to 47.8%, respectively. The SRS-22 self-image score of patients who had a UIV in the upper thoracic region reached MCID significantly more than that of patients who had a UIV in the thoracolumbar region (70.6% vs 41.9%, p = 0.0281). All other outcomes were similar for UIVs of upper thoracic and thoracolumbar regions. Comparison of patients whose spines were above or below the radiographic thresholds associated with disability indicated similar rates of meeting MCID and SCB for HRQOL at the 2-year follow-up. CONCLUSIONS: Outcomes for patients having UIVs in the upper thoracic region were no more likely to meet MCID or SCB than for those having UIVs in the thoracolumbar region, except for the MCID in the SRS-22 self-image measure. The HRQOL outcomes in patients who had optimal sagittal correction according to radiographic thresholds determined preoperatively were not significantly more likely to reach MCID or SCB at the 2-year follow-up. Future work needs to determine whether the Schwab preoperative radiographic thresholds for severe disability apply in postoperative settings.
KW - 3-Column osteotomy
KW - Minimum clinically important difference
KW - Pedicle subtraction osteotomy
KW - Spinal deformity
KW - Spinal disorders
KW - Substantial clinical benefit
KW - Vertebral column resection
UR - http://www.scopus.com/inward/record.url?scp=84952720383&partnerID=8YFLogxK
U2 - 10.3171/2014.12.SPINE141031
DO - 10.3171/2014.12.SPINE141031
M3 - Article
C2 - 26091440
AN - SCOPUS:84952720383
SN - 1547-5654
VL - 23
SP - 340
EP - 348
JO - Journal of Neurosurgery: Spine
JF - Journal of Neurosurgery: Spine
IS - 3
ER -